Investing.com - Encompass Health (NYSE: EHC) reported fourth quarter EPS of $0.88, $0.04 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.14B versus the consensus estimate of $1.12B.
Guidance
Encompass Health sees FY 2023 EPS of $2.87-$3.16 versus the analyst consensus of $3.25.
Encompass Health sees FY 2023 revenue of $4.68B-$4.76B versus the analyst consensus of $4.67B.
Encompass Health's stock price closed at $58.87. It is up 2.97% in the last 3 months and down -5.28% in the last 12 months.
Encompass Health saw 4 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Encompass Health's stock price’s past reactions to earnings here.
According to InvestingPro, Encompass Health's Financial Health score is "good performance".
Check out Encompass Health's recent earnings performance, and Encompass Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar